Milica Borovcanin1, Ivan Jovanovic2, Gordana Radosavljevic2, Slavica Djukic Dejanovic3, Vesna Stefanovic4, Nebojsa Arsenijevic2, Miodrag L Lukic2. 1. Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia. Electronic address: milicaborovcanin@yahoo.com. 2. Center for Molecular Medicine and Stem Cell Research, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia. 3. Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia. 4. Clinic for Mental Disorders "Dr Laza Lazarevic", Belgrade, Serbia.
Abstract
OBJECTIVE: We recently reported that the type-2 cytokine response is increased in schizophrenia. The aim of this study was to analyse the effects of antipsychotic drugs on the serum levels of type-1 (TNF-α, IFN-γ), type-2 (IL-4, IL-10), type-17 (IL-17) and regulatory cytokines (TGF-β, IL-27 and IL-6). METHODS: Cytokine measurements in the patients were performed on day 0 and day 30 of the treatment using standard ELISA assays. Three groups of subjects were studied: patients that were unmedicated with First Episode Psychosis (FEP; n=88), patients that were treated with antipsychotics with Schizophrenia in relapse (SC in relapse; n=45) and healthy controls (n=36). RESULTS: TGF-β levels were increased in both patient groups and were further enhanced after treatment in the FEP group (p=0.014) but not in the SC relapse group. Antipsychotic treatment was correlated with lower levels of IL-4, IL-6 and IL-27 (p<0.005) in the FEP group. Finally, the serum levels of IL-17 were not significantly altered between the two measurements but were significantly lower in the FEP group (p<0.001) when compared with healthy controls. After therapy, patients with SC who were in relapse had decreased serum levels of IL-4 (p=0.006) and IL-6 (p=0.007). We also observed a weak negative correlation between the IFN-γ/TGF-β ratio and the total PANSS score and between the IL-17/TGF-β ratio and the negative and general psychopathology subscales. CONCLUSION: The increased type-2 cytokine serum levels in schizophrenia appear to be downregulated by antipsychotic treatment.
OBJECTIVE: We recently reported that the type-2 cytokine response is increased in schizophrenia. The aim of this study was to analyse the effects of antipsychotic drugs on the serum levels of type-1 (TNF-α, IFN-γ), type-2 (IL-4, IL-10), type-17 (IL-17) and regulatory cytokines (TGF-β, IL-27 and IL-6). METHODS: Cytokine measurements in the patients were performed on day 0 and day 30 of the treatment using standard ELISA assays. Three groups of subjects were studied: patients that were unmedicated with First Episode Psychosis (FEP; n=88), patients that were treated with antipsychotics with Schizophrenia in relapse (SC in relapse; n=45) and healthy controls (n=36). RESULTS: TGF-β levels were increased in both patient groups and were further enhanced after treatment in the FEP group (p=0.014) but not in the SC relapse group. Antipsychotic treatment was correlated with lower levels of IL-4, IL-6 and IL-27 (p<0.005) in the FEP group. Finally, the serum levels of IL-17 were not significantly altered between the two measurements but were significantly lower in the FEP group (p<0.001) when compared with healthy controls. After therapy, patients with SC who were in relapse had decreased serum levels of IL-4 (p=0.006) and IL-6 (p=0.007). We also observed a weak negative correlation between the IFN-γ/TGF-β ratio and the total PANSS score and between the IL-17/TGF-β ratio and the negative and general psychopathology subscales. CONCLUSION: The increased type-2 cytokine serum levels in schizophrenia appear to be downregulated by antipsychotic treatment.
Authors: Paulo L Lizano; Matcheri S Keshavan; Neeraj Tandon; Ian T Mathew; Suraj Sarvode Mothi; Debra M Montrose; Jeffrey K Yao Journal: Schizophr Res Date: 2015-12-11 Impact factor: 4.939
Authors: Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang Journal: Psychopharmacology (Berl) Date: 2014-06-24 Impact factor: 4.530
Authors: Peter Manu; Christoph U Correll; Martien Wampers; Alex J Mitchell; Michel Probst; Davy Vancampfort; Marc De Hert Journal: World Psychiatry Date: 2014-06 Impact factor: 49.548
Authors: Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste Journal: Am J Geriatr Psychiatry Date: 2016-10-17 Impact factor: 4.105